172 related articles for article (PubMed ID: 31931362)
1. Dihydroartemisinin inhibits the proliferation of IgAN mesangial cells through the mTOR signaling pathway.
Xia M; Liu D; Tang X; Liu Y; Liu H; Liu Y; Chen G; Liu H
Int Immunopharmacol; 2020 Mar; 80():106125. PubMed ID: 31931362
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibitors attenuate P-aIgA1-induced cell proliferation and extracellular matrix synthesis in human renal mesangial cells in vitro.
Dai Q; Liu J; Du YL; Hao X; Ying J; Tan Y; He LQ; Wang WM; Chen N
Acta Pharmacol Sin; 2016 Feb; 37(2):228-34. PubMed ID: 26775659
[TBL] [Abstract][Full Text] [Related]
3. The Akt/mTOR/p70S6K pathway is activated in IgA nephropathy and rapamycin may represent a viable treatment option.
Tian J; Wang Y; Guo H; Li R
Exp Mol Pathol; 2015 Dec; 99(3):435-40. PubMed ID: 26297427
[TBL] [Abstract][Full Text] [Related]
4. Rapamycin Enhances Repressed Autophagy and Attenuates Aggressive Progression in a Rat Model of IgA Nephropathy.
Liu D; Liu Y; Chen G; He L; Tang C; Wang C; Yang D; Li H; Dong Z; Liu H
Am J Nephrol; 2017; 45(4):293-300. PubMed ID: 28237991
[TBL] [Abstract][Full Text] [Related]
5. Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells.
Wang Y; Zhao MH; Zhang YK; Li XM; Wang HY
Clin Exp Immunol; 2004 Apr; 136(1):168-75. PubMed ID: 15030528
[TBL] [Abstract][Full Text] [Related]
6. Jixuecao (Herba Centellae Asiaticae) alleviates mesangial cell proliferation in IgA nephropathy by inducing mitofusin 2 expression.
Chen H; Du Y; Li Y; Zeng J; Miao J; Jiang X
J Tradit Chin Med; 2019 Jun; 39(3):346-355. PubMed ID: 32186007
[TBL] [Abstract][Full Text] [Related]
7. The IgA1 immune complex-mediated activation of the MAPK/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA nephropathy.
Tamouza H; Chemouny JM; Raskova Kafkova L; Berthelot L; Flamant M; Demion M; Mesnard L; Paubelle E; Walker F; Julian BA; Tissandié E; Tiwari MK; Camara NO; Vrtovsnik F; Benhamou M; Novak J; Monteiro RC; Moura IC
Kidney Int; 2012 Dec; 82(12):1284-96. PubMed ID: 22951891
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin inhibits PDGF-induced mesangial cell proliferation: regulation of mammalian target of rapamycin-mediated survival pathway by adenosine 5-monophosphate-activated protein kinase.
Su YX; Deng HC; Zhang MX; Long J; Peng ZG
Horm Metab Res; 2012 Jan; 44(1):21-7. PubMed ID: 22105511
[TBL] [Abstract][Full Text] [Related]
9. Pathogenic role of glycan-specific IgG antibodies in IgA nephropathy.
Zhao YF; Zhu L; Liu LJ; Shi SF; Lv JC; Zhang H
BMC Nephrol; 2017 Sep; 18(1):301. PubMed ID: 28969604
[TBL] [Abstract][Full Text] [Related]
10. Rapamycin Induces Autophagy and Reduces the Apoptosis of Podocytes Under a Stimulated Condition of Immunoglobulin A Nephropathy.
Liang S; Jin J; Lin B; Gong J; Li Y; He Q
Kidney Blood Press Res; 2017; 42(1):177-187. PubMed ID: 28427080
[TBL] [Abstract][Full Text] [Related]
11. Renoprotective effects of artemisinin and hydroxychloroquine combination therapy on IgA nephropathy via suppressing NF-κB signaling and NLRP3 inflammasome activation by exosomes in rats.
Bai L; Li J; Li H; Song J; Zhou Y; Lu R; Liu B; Pang Y; Zhang P; Chen J; Liu X; Wu J; Liang C; Zhou J
Biochem Pharmacol; 2019 Nov; 169():113619. PubMed ID: 31465776
[TBL] [Abstract][Full Text] [Related]
12. Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1.
Ebefors K; Liu P; Lassén E; Elvin J; Candemark E; Levan K; Haraldsson B; Nyström J
BMC Nephrol; 2016 Apr; 17():40. PubMed ID: 27044423
[TBL] [Abstract][Full Text] [Related]
13. Liuwei Dihuang Pills Inhibit Podocyte Injury and Alleviate IgA Nephropathy by Directly Altering Mesangial Cell-Derived Exosome Function and Secretion.
Zhu X; Shen X; Lin B; Fang J; Jin J; He Q
Front Pharmacol; 2022; 13():889008. PubMed ID: 35899112
[No Abstract] [Full Text] [Related]
14. Rapamycin ameliorates IgA nephropathy via cell cycle-dependent mechanisms.
Tian J; Wang Y; Liu X; Zhou X; Li R
Exp Biol Med (Maywood); 2015 Jul; 240(7):936-45. PubMed ID: 25349217
[TBL] [Abstract][Full Text] [Related]
15. The protective effect and mechanism of rapamycin in the rat model of IgA nephropathy.
Guo N; Liu S; Bow LM; Cui X; Zhang L; Xu S; Lu S; Tian J
Ren Fail; 2019 Nov; 41(1):334-339. PubMed ID: 31057050
[TBL] [Abstract][Full Text] [Related]
16. Triptolide promotes autophagy to inhibit mesangial cell proliferation in IgA nephropathy via the CARD9/p38 MAPK pathway.
Zhao L; Lan Z; Peng L; Wan L; Liu D; Tan X; Tang C; Chen G; Liu H
Cell Prolif; 2022 Sep; 55(9):e13278. PubMed ID: 35733381
[TBL] [Abstract][Full Text] [Related]
17. Ursolic Acid Attenuates High Glucose-Mediated Mesangial Cell Injury by Inhibiting the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin (PI3K/Akt/mTOR) Signaling Pathway.
Wang EM; Fan QL; Yue Y; Xu L
Med Sci Monit; 2018 Feb; 24():846-854. PubMed ID: 29428962
[TBL] [Abstract][Full Text] [Related]
18. EIF2α/ATF4 pathway enhances proliferation of mesangial cell via cyclin D1 during endoplasmic reticulum stress in IgA nephropathy.
Lan Z; Zhao L; Peng L; Wan L; Liu D; Tang C; Chen G; Liu Y; Liu H
Clin Immunol; 2023 Dec; 257():109840. PubMed ID: 37939913
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppressive effect of artemisinin and hydroxychloroquine combination therapy on IgA nephropathy via regulating the differentiation of CD4+ T cell subsets in rats.
Bai L; Li H; Li J; Song J; Zhou Y; Liu B; Lu R; Zhang P; Chen J; Chen D; Pang Y; Liu X; Wu J; Liang C; Zhou J
Int Immunopharmacol; 2019 May; 70():313-323. PubMed ID: 30852287
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of miR‑214-3p attenuates mesangial hypercellularity by targeting PTEN‑mediated JNK/c-Jun signaling in IgA nephropathy.
Li Y; Xia M; Peng L; Liu H; Chen G; Wang C; Yuan D; Liu Y; Liu H
Int J Biol Sci; 2021; 17(13):3343-3355. PubMed ID: 34512151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
